Literature DB >> 25043687

Down-regulation of the P-glycoprotein relevant for multidrug resistance by intracellular acidification through the crosstalk of MAPK signaling pathways.

Weina Jin1, Ying Lu2, Qinghua Li3, Jian Wang3, Hongju Zhang3, Guoqiang Chang3, Yani Lin3, Tianxiang Pang4.   

Abstract

In our previous study, we have found that the tumor multidrug resistance mediated by P-glycoprotein could be reversed by sustained intracellular acidification through down-regulating the multidrug resistance gene 1 mRNA and P-glycoprotein expression. However, the molecular events linking the intracellular acidification and the regulation of P-glycoprotein remain unclear. In the present study, the molecular pathways involved in the regulation of P-glycoprotein expression by the intracellular acidification were investigated. We found that the P-glycoprotein expression was down-regulated by the intracellular acidification through inhibition of p38 mitogen-activated protein kinase (MAPK) and the activation of c-Jun N-terminal kinase (JNK) in the resisitant K562/DOX cells. In the sensitive K562 and HL60 cell lines, the changes of the p38 MAPK expression after the acidification are not as obvious as that of K562/DOX cells, but the activation of extracellular signal-regulated kinase (ERK) is also observed, which indicates that the down-regulation of p38 MAPK by the intracellular acidification might be the resistant cell line specific. Blockade of ERK and JNK signaling by the inhibitors or RNA interference increased p38MAPK activities suggesting that cross-talk within MAPKs is also important for this response. Our study provides the first direct evidence that the reversal of P-glycoprotein-mediated multidrug resistance by intracellular acidification is mediated by the crosstalk of MAPK signaling pathways.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Intracellular acidification; Intracellular pH; Mitogen-activated protein kinase; Multidrug resistance; P-glycoprotein

Mesh:

Substances:

Year:  2014        PMID: 25043687     DOI: 10.1016/j.biocel.2014.06.016

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  8 in total

1.  Hypomethylation agent decitabine restores drug sensitivity by depressing P-glycoprotein activity through MAPK signaling pathway.

Authors:  Huihan Wang; Xiaobin Wang; Aijun Liao; Zhuogang Liu
Journal:  Mol Cell Biochem       Date:  2017-04-12       Impact factor: 3.396

2.  MicroRNA-144 targets APP to regulate AML1/ETO+ leukemia cell migration via the p-ERK/c-Myc/MMP-2 pathway.

Authors:  Ling Jiang; Wei Meng; Guopan Yu; Changxin Yin; Zhixiang Wang; Libin Liao; Fanyi Meng
Journal:  Oncol Lett       Date:  2019-06-14       Impact factor: 2.967

Review 3.  The complex relationship between multiple drug resistance and the tumor pH gradient: a review.

Authors:  Tomas Koltai
Journal:  Cancer Drug Resist       Date:  2022-04-03

4.  Involvement of p38 MAPK in the Drug Resistance of Refractory Epilepsy Through the Regulation Multidrug Resistance-Associated Protein 1.

Authors:  Cuicui Wang; Zhen Hong; Yinghui Chen
Journal:  Neurochem Res       Date:  2015-06-20       Impact factor: 3.996

5.  Regulation of MAPKs Signaling Contributes to the Growth Inhibition of 1,7-Dihydroxy-3,4-dimethoxyxanthone on Multidrug Resistance A549/Taxol Cells.

Authors:  Jian Zuo; Hui Jiang; Yan-Hong Zhu; Ya-Qin Wang; Wen Zhang; Jia-Jie Luan
Journal:  Evid Based Complement Alternat Med       Date:  2016-06-15       Impact factor: 2.629

6.  Tomentodione M sensitizes multidrug resistant cancer cells by decreasing P-glycoprotein via inhibition of p38 MAPK signaling.

Authors:  Xu-Wei Zhou; Yuan-Zheng Xia; Ya-Long Zhang; Jian-Guang Luo; Chao Han; Hao Zhang; Chao Zhang; Lei Yang; Ling-Yi Kong
Journal:  Oncotarget       Date:  2017-10-19

Review 7.  The Potential of Vitamin D-Regulated Intracellular Signaling Pathways as Targets for Myeloid Leukemia Therapy.

Authors:  Elzbieta Gocek; George P Studzinski
Journal:  J Clin Med       Date:  2015-03-25       Impact factor: 4.241

8.  Asclepiasterol, a novel C21 steroidal glycoside derived from Asclepias curassavica, reverses tumor multidrug resistance by down-regulating P-glycoprotein expression.

Authors:  Wei-Qi Yuan; Rong-Rong Zhang; Jun Wang; Yan Ma; Wen-Xue Li; Ren-Wang Jiang; Shao-Hui Cai
Journal:  Oncotarget       Date:  2016-05-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.